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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1833Targeting Structural Remodeling of the MyocardiumArantxa Gonza´lez, Susana Ravassa, Javier Beaumont, Begoña Lo´pez, Javier Dı´ez
Classical therapy of heart failure is based on treatment of its pre-disposing/triggering factors
and of the neurohumoral activation. Gonza´lez and colleagues review the current and
emerging science that proposes direct intervention on the pathological structural remodeling.
The potential targets for intervention include cardiomyocyte growth and death, inflammation,
alterations of collagen matrix, and microvascular rarefaction. Recent insights from
experimental and pilot clinical studies are reviewed.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1844No Difference in Late-Loss Between EES and SESKyung Woo Park, In-Ho Chae, Do-Sun Lim, Kyoo-Rok Han, Han-Mo Yang, Hae-Young Lee,
Hyun-Jae Kang, Bon-Kwon Koo, Taehoon Ahn, Jung-Han Yoon, Myung-Ho Jeong, Taek-Jong
Hong, Woo-Young Chung, Sang-Ho Jo, Young-Jin Choi, Seung-Ho Hur, Hyuck-Moon Kwon,
Dong-Woon Jeon, Byung-Ok Kim, Si-Hoon Park, Nam-Ho Lee, Hui-Kyung Jeon, Hyeon-Cheol Gwon,
Yang-Soo Jang, Hyo-Soo Kim
The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After
Stenting) trial compared the angiographic outcomes of everolimus-eluting stents (EES) and
sirolimus-eluting stents (SES) in a trial powered to detect noninferiority for in-segment late
loss at 9 months. Clinical follow-up was available in 1,428 patients and angiographic follow-up in
924 patients (1,215 lesions). The primary endpoint of the study was 0.11 and 0.06 mm for
EES and SES, respectively (p for noninferiority  0.04). The incidence of clinical endpoints,
including target lesion failure and stent thrombosis, was not statistically different between the
2 groups. These results suggest equivalence for angiographic and clinical outcomes between
EES and SES.
Editorial Comment: Fernando Alfonso, Cristina Fernandez, p. 1855(continued on page A-20)
OCTOBER 25, 2011 (continued) A-20INTERVENTIONAL CARDIOLOGY1859Benefits of DES Are Seen Regardless of Kidney FunctionThomas T. Tsai, John C. Messenger, J. Matthew Brennan, Uptal D. Patel, David Dai, Robert N. Piana,
Kevin J. Anstrom, Eric L. Eisenstein, Rachel S. Dokholyan, Eric D. Peterson, Pamela S. Douglas
Tsai and colleagues used data from the National Cardiovascular Data Registry database to
compare the safety and efficacy of drug-eluting stents (DES) compared with bare-metal stents
(BMS) in older patients with chronic kidney disease (CKD). The glomerular filtration rate
(GFR) was calculated among almost 300,000 patients 65 years of age that underwent stent
implantation. In propensity-matched pairs, the receipt of a DES versus a BMS in patients
with normal renal function was associated with significant reductions in subsequent rates of
revascularization, MI, and death, but no difference in bleeding. For patients with CKD, lower
MI and mortality rates were observed with DES compared with BMS, but there were no
differences in rates of revascularization. This large study confirms the superiority of DES to
BMS in elderly patients regardless of kidney function.HEART FAILURE1870Leptin May Modulate the Risk of Heart Failure in Older MenS. Goya Wannamethee, A. Gerald Shaper, Peter H. Whincup, Lucy Lennon, Naveed Sattar
Leptin has been proposed as a potential link between obesity and heart failure (HF), with
experimental evidence suggesting that leptin regulates myocardial metabolism, promotes
cardiomyocyte hypertrophy, and may influence cardiac remodeling. Wannamethee and
colleagues explored the relationship between body mass index (BMI), waist circumference
(WC), and incident HF in 4,000 elderly men. Increased BMI was associated with an
increased risk of HF in men with and without pre-existing coronary heart disease (CHD).
Elevated leptin was associated with an increased risk of HF in men without pre-existing
CHD, independent of BMI; however, no association was seen in those with pre-existing
CHD. Leptin may modulate the risk of obesity-induced HF, but it appears to be a complex
relationship.
Editorial Comment: Anita Deswal, p. 1878(continued on page A-21)
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1881Using NT-proBNP to Guide Outpatient Therapy
May Improve Outcomes for Patients With Systolic DysfunctionJames L. Januzzi, Jr., Shafiq U. Rehman, Asim A. Mohammed, Anju Bhardwaj, Linda Barajas,
Justine Barajas, Han-Na Kim, Aaron L. Baggish, Rory B. Weiner, Annabel Chen-Tournoux,
Jane E. Marshall, Stephanie A. Moore, William D. Carlson, Gregory D. Lewis, Jordan Shin,
Dorothy Sullivan, Kimberly Parks, Thomas J. Wang, Shawn A. Gregory, Shanmugam Uthamalingam,
Marc J. Semigran
Januzzi and colleagues performed a randomized trial to determine if heart failure (HF)
therapy guided by amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels is
superior to standard of care (SOC) management. Subjects with systolic dysfunction and
elevated NT-proBNP were randomized to SOC or to targeting a NT-proBNP concentration
1,000 pg/ml. There were fewer clinical events in the subjects assigned to the NT-proBNP
group, and these patients also had more outpatient visits and more aggressive medication
titration. NT-proBNP–guided patients also had greater improvements in quality of life and
more improvements in left ventricular ejection fraction. NT-proBNP–guided therapy may
improve clinical and echocardiographic endpoints compared with SOC.Editorial Comment: Alan Maisel, p. 1890HEART RHYTHM DISORDERS
1893New Technique Uses ECG Imaging to
Noninvasively Characterize Electrophysiologic SubstratePhillip S. Cuculich, Junjie Zhang, Yong Wang, Kavit A. Desouza, Ramya Vijayakumar, Pamela K. Woodard,
Yoram Rudy
Cuculich and colleagues studied the utility of electrocardiographic imaging (ECGI) to
noninvasively image the electrophysiologic substrate of human ventricles after myocardial
infarction. ECGI uses 256 surface electrocardiographic (ECG) leads to construct epicardial
electrograms, along with computed tomography imaging for localization. When these results
were compared to other data, ECGI was found to colocalize the epicardial electrical scar to
the anatomic scar with a high degree of accuracy and to identify the source of late potentials
in the border zone between healthy and scar tissue. This noninvasive technique may be useful
in the future for identifying patients at increased risk for ventricular arrhythmias after
myocardial infarction.(continued on page A-24)
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EPEDIATRIC CARDIOLOGY1903Pediatric Cardiac Tumors and the Risks of ArrhythmiasChristina Y. Miyake, Pedro J. Del Nido, Mark E. Alexander, Frank Cecchin, Charles I. Berul,
John K. Triedman, Tal Geva, Edward P. Walsh
Miyake and colleagues performed a retrospective review of pediatric patients with primary
cardiac tumors. A total of 173 patients were identified: 106 rhabdomyoma, 25 fibroma,
14 myxoma, 6 vascular, 4 teratoma, 3 lipoma, and 15 other. The median age at diagnosis was
7 months. Of these, 24% had clinically significant arrhythmias. Two-thirds of patients with
large fibromas had at least 1 episode of ventricular tachycardia (VT). Surgical excision was
performed in 62 cases, with rhythm treatment being one of the indications in 20 patients.
Clinically significant arrhythmias were eliminated in 18 of these 20 patients after surgical
resection. These results help to define the arrhythmic risks associated with pediatric cardiac
tumors and suggest that surgical excision may be an effective therapy.EXPEDITED PUBLICATIONS EXPEDITED PUBLICATIONS1910Prosthesis-Patient Mismatch Impairs Hemodynamic and Clinical Outcomes After TAVISee Hooi Ewe, Manuela Muratori, Victoria Delgado, Mauro Pepi, Gloria Tamborini, Laura Fusini,
Robert Klautz, Paola Gripari, Jeroen J. Bax, Melissa Fusari, Martin J. Schalij, Nina Ajmone Marsan
Ewe and colleagues studied the midterm hemodynamic and clinical impact of prosthesis-
patient mismatch (PPM) in patients after transcatheter aortic valve implantation (TAVI).
PPM was defined as an indexed effective orifice area 0.85 cm2/m2 and was found in 18%.
atients with PPM had a smaller reduction in mean transaortic gradient, had limited left
entricular mass regression, and were less likely to improve their New York Heart Association
unctional class. PPM occurs frequently after TAVI and has important negative clinical
mpacts.ditorial Comment: E. Murat Tuzcu, p. 1919
